13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001892770
Total reported value
$189.2M
$189.2M
84 檔
66.7%
During the Q1 2025 filing period, Knott David M Jr (CIK: 0001892770) submitted its Form 13F report to the U.S. SEC, disclosing a tracked public equity portfolio valued at $189.2M across 84 reported positions.
During Q1 2025, Knott David M Jr's portfolio maintained high stability with no major positional turnover, reflecting a continuous long-term holding approach.
In terms of portfolio concentration, the top 5 core holdings (including CLMT, APO, JAAA) accounted for 66.7% of total reported equity market value during Q1 2025.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | CLMT | Calumet Inc | Stock-Other | 19.73% | — | -9.70% | |
| 2 | APO | Apollo Global Management Inc | Stock-Financials | 14.54% | -0.85% | — | |
| 3 | JAAA | Janus Henderson Aaa Clo ETF | ETF-Other | 13.20% | -0.30% | -6.54% | |
| 4 | GOOG | Alphabet Inc-cl C | Stock-Comm Services | 8.27% | +1.46% | — | |
| 5 | DCGO | Docgo Inc | Stock-Other | 3.82% | -0.27% | — | |
| 6 | PFE | Pfizer Inc | Stock-Healthcare | 3.04% | -0.13% | — | |
| 7 | XERS | Xeris Biopharma Holdings Inc | Stock-Other | 2.88% | +0.78% | +11.00% | |
| 8 | VRNA | Verona Pharma PLC - Adr | Stock-Other | 2.64% | — | -44.76% | |
| 9 | JPM | Jpmorgan Chase & Co | Stock-Financials | 2.43% | -0.28% | — | |
| 10 | CPRX | Catalyst Pharmaceuticals Inc | Stock-Healthcare | 2.43% | -1.77% | EXIT | |
| 11 | TVTX | Travere Therapeutics Inc | Stock-Other | 1.93% | +1.93% | — | |
| 12 | PTGX | Protagonist Therapeutics Inc | Stock-Other | 1.73% | +0.13% | +45.13% | |
| 13 | BCRX | Biocryst Pharmaceuticals Inc | Stock-Other | 1.63% | — | +4.55% | |
| 14 | ✓ | Avadel Pharmaceuticals PLC ADR | Stock-Other | 1.57% | — | +22.80% | |
| 15 | ESGRP | Enstar Group Limited - Deposita | Stock-Other | 1.18% | — | — | |
| 16 | ARDX | Ardelyx Inc | Stock-Other | 1.14% | -0.03% | -19.35% | |
| 17 | OABI | Omniab Inc | Stock-Other | 1.11% | — | -10.25% | |
| 18 | CSX | Csx CORP | Stock-Industrials | 0.97% | — | — | |
| 19 | AB | Alliancebernstein Holding LP | Stock-Other | 0.87% | -0.18% | — | |
| 20 | ICLO | Invesco Aaa Clo F/r Note ETF | ETF-Other | 0.85% | — | -65.01% | |
| 21 | RARE | Ultragenyx Pharmaceutical In | Stock-Other | 0.82% | +0.26% | — | |
| 22 | SNDX | Syndax Pharmaceuticals Inc | Stock-Other | 0.74% | -0.82% | — | |
| 23 | MYGN | Myriad Genetics Inc | Stock-Other | 0.67% | — | — | |
| 24 | COGT | Cogent Biosciences Inc | Stock-Other | 0.60% | -0.11% | — | |
| 25 | CLOZ | Eldridge Bbb-b Clo ETF | ETF-Other | 0.60% | -0.06% | — | |
| 26 | REGN | Regeneron Pharmaceuticals | Stock-Healthcare | 0.60% | — | — | |
| 27 | BMY | Bristol-myers Squibb Co | Stock-Healthcare | 0.55% | -0.43% | — | |
| 28 | COLL | Collegium Pharmaceutical Inc | Stock-Other | 0.54% | — | +16.84% | |
| 29 | XBI | Ss Spdr S&p Biotech ETF | ETF-Tech | 0.52% | +0.11% | +36.43% | |
| 30 | RHP | Ryman Hospitality Properties | Stock-Real Estate | 0.52% | +0.03% | — | |
| 31 | ABBV | Abbvie Inc | Stock-Healthcare | 0.50% | — | — | |
| 32 | ✓ | Stock-Other | 0.46% | — | — | ||
| 33 | KMB | Kimberly-clark CORP | Stock-Consumer Staples | 0.40% | — | — | |
| 34 | MGTX | MeiraGTx Holdings plc | Stock-Other | 0.40% | — | +31.48% | |
| 35 | ATRC | Atricure Inc | Stock-Other | 0.37% | -0.11% | — | |
| 36 | MREO | Mereo Biopharma Group Pl-adr | Stock-Other | 0.34% | -0.06% | EXIT | |
| 37 | TECX | Tectonic Therapeutic Inc | Stock-Other | 0.33% | — | — | |
| 38 | 6D8 | Dupont De Nemours Inc | Stock-Other | 0.33% | -0.10% | EXIT | |
| 39 | CTVA | Corteva Inc | Stock-Materials | 0.33% | -0.01% | -4.43% | |
| 40 | ATYR | Atyr Pharma Inc | Stock-Other | 0.32% | — | -27.50% | |
| 41 | AUTL | Autolus Therapeutics PLC | Stock-Other | 0.31% | — | — | |
| 42 | MDLZ | Mondelez International Inc-a | Stock-Consumer Staples | 0.29% | -0.01% | — | |
| 43 | ✓ | Inozyme Pharma Inc | Stock-Other | 0.29% | — | -4.14% | |
| 44 | MSFT | Microsoft CORP | Stock-Tech | 0.28% | -0.03% | — | |
| 45 | AAPL | Apple Inc | Stock-Tech | 0.26% | — | — | |
| 46 | IBM | Intl Business Machines CORP | Stock-Tech | 0.25% | +0.01% | — | |
| 47 | XENE | Xenon Pharmaceuticals Inc | Stock-Other | 0.25% | — | -23.96% | |
| 48 | CNQ | Canadian Natural Resources | Stock-Energy | 0.24% | -0.14% | — | |
| 49 | SLDB | Solid Biosciences Inc | Stock-Other | 0.23% | +0.10% | — | |
| 50 | HELP | Cybin Inc | Stock-Other | 0.20% | +0.29% | +10.64% |
According to official SEC Form 13F filings, Knott David M Jr reported a total U.S. public equity portfolio value of $189.2M across 84 disclosed positions in Q1 2025.
During Q1 2025, Knott David M Jr's top holdings by market value included CLMT (19.7%)、APO (14.5%)、JAAA (13.2%). The largest single position, CLMT, represented 19.7% of total portfolio value.
In Q1 2025, Knott David M Jr made 0 total portfolio adjustments, initiating 0 new buys, adding to 0 positions, trimming 0 holdings, and fully liquidating 0 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.